HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kalindi Bakshi Selected Research

S 24795

3/2010S 24795 limits beta-amyloid-alpha7 nicotinic receptor interaction and reduces Alzheimer's disease-like pathologies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kalindi Bakshi Research Topics

Disease

3Alzheimer Disease (Alzheimer's Disease)
01/2017 - 03/2010
2Schizophrenia (Dementia Praecox)
01/2020 - 07/2006
1Neuroinflammatory Diseases
01/2017
1Amyloid Plaque
07/2012

Drug/Important Bio-Agent (IBA)

2SimufilamIBA
01/2017 - 07/2012
2FilaminsIBA
01/2017 - 07/2012
1Amyloid (Amyloid Fibrils)IBA
07/2012
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
03/2010
1S 24795IBA
03/2010
1Amyloid beta-PeptidesIBA
03/2010
1ErbB Receptors (EGF Receptor)IBA
07/2006
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2006
1N-Methylaspartate (NMDA)IBA
07/2006
1NeuregulinsIBA
07/2006
1Neuregulin-1 (Neuregulin 1)IBA
07/2006

Therapy/Procedure

1Lasers (Laser)
01/2020